Published Date: 17 Feb 2023
Researchers at the University of East Anglia are on the verge of developing a new generation of cancer treatment. The futuristic sound treatment will work by turning on the light in the nearby LED.
Read Full NewsResearchers seek to understand why Asian women fare better with the disease.
By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.
1.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
2.
According to new studies, some cancer patients can safely forego radiation therapy.
3.
Second opinions don't significantly delay breast cancer treatment
4.
Pickleball program boosts health and wellness for cancer survivors, study finds
5.
'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested
1.
Contemporary Frameworks in Oncology Across Clinical Settings
2.
Practical Concepts in Hematology and Patient Outcomes
3.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
4.
Epigenetic Signatures for Multi-Cancer Screening
5.
Synovial Sarcoma of Female Urethra: Case Report and Literature Review
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation